Table 5.
Number (%) of patients by the last prescribed dosage levels and treatment status in patients whose dosage is available, that is, not PRN
| Treatment status | |||||
|---|---|---|---|---|---|
| Changed | Stayed | Discontinued | Died | Total | |
| Olanzapine (mg/day) | |||||
| <2.5 | 1 (5.3) | 9 (47.4) | 9 (47.4) | 0 (0) | 19 (1.5) |
| 2.5–5 | 32 (7.0) | 173 (37.7) | 240 (52.3) | 14 (3.1) | 459 (36.2) |
| ≥5 | 58 (7.3) | 292 (37.0) | 411 (52.0) | 29 (3.7) | 790 (62.3) |
| Quetiapine (mg/day) | |||||
| <50 | 160 (5.5) | 1044 (36.1) | 1603 (55.4) | 86 (3.0) | 2893 (47.0) |
| 50–100 | 107 (5.4) | 775 (39.1) | 1038 (52.3) | 63 (3.2) | 1983 (32.2) |
| ≥100 | 81 (6.3) | 586 (45.7) | 578 (45.1) | 37 (2.9) | 1282 (20.8) |
| Risperidone (mg/day) | |||||
| <0.5 | 48 (5.2) | 338 (36.4) | 515 (55.5) | 27 (2.9) | 928 (19.1) |
| 0.5–1 | 127 (6.7) | 677 (35.9) | 1023 (54.3) | 57 (3.0) | 1884 (38.8) |
| ≥1 | 128 (6.3) | 778 (38.2) | 1044 (51.2) | 89 (4.4) | 2039 (42.0) |
For each antipsychotic, the highest dosage level corresponds to adverse event dosage range.
Note: Percentages add to 100% for each row within each dosage level of each antipsychotic, except the last total column, which adds to 100% within each antipsychotics.